Navigation Links
George Mason University researchers target breast cancer in 3 trials
Date:11/1/2012

Fairfax, Va. -- A malarial drug is showing promise in stopping breast cancer before it starts, Mason researchers are discovering during a clinical trial.

"The bold long-term goal is a short-term oral treatment that prevents breast cancer by killing the precursor cells that initiate breast cancer," says Lance Liotta, co-director of Mason's Center for Applied Proteomics and Molecular Medicine (CAPMM). "And it's looking hopeful."

The PINC trial (Preventing Invasive Neoplasia with Chloroquine) targets ductal carcinoma in situ, or DCIS, the most common type of pre-invasive breast cancer. Chloroquine is a drug given to prevent or treat malaria; it's showing promise in the early phase of the PINC trial.

CAPMM has three ongoing breast cancer research projects, including the PINC trial, which span the full scope of breast cancer's impact on patients.

In the PINC trial, DCIS is the focus. DCIS shows up as white spots in the MRI of a breast. Those white spots are calcifications that may mark the milk ducts where DCIS cells are growing, says Virginia Espina, assistant research professor at CAPMM. Not all DCIS becomes cancer, but all breast cancer goes through the DCIS stage, she says.

If the patient is diagnosed with DCIS after a biopsy, then she can enter the trial, says Espina, adding that the study doesn't interfere with standard medical treatment. Mason researchers are working with Kirsten Edmiston, a surgeon at Inova Fairfax Hospital who recruits the patients and clinically directs the trial.

While patients are waiting between their diagnosis and the surgery, they take chloroquine once a week for four weeks, Espina says.

A significant reduction in the lesion's size is the sought-after outcome, Espina says. The widely prescribed malaria drug chloroquine has few side effects a rare rash is one, Espina says. There could come a day when chloroquine is taken by women worldwide to prevent breast cancer.

<
'/>"/>
Contact: Michele McDonald
mmcdon15@gmu.edu
703-993-8781
George Mason University
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. James George, MD: 2012 ASH Wallace H. Coulter Award for Lifetime Achievement in Hematology
2. Georgetown physician leads national resveratrol study for Alzheimers disease
3. Research prizes from the Carlsberg Foundation to researchers from University of Copenhagen
4. University of Houston India Studies Program presents Circuits of Empire: India as Metropole
5. Mercyhurst University presents new research on managing spinal injuries to NFL
6. NTU and University of Warwick boost brainpower in global neuroscience research
7. CDC funds Wayne State University research to understand, prevent teen dating violence
8. Wayne State University researcher recognized by American Psychological Association
9. University of Minnesota chemist named 1 of Popular Sciences Brilliant 10
10. University of Maryland study: Neonatal heart stem cells may help mend kids broken hearts
11. Aarhus University to inaugurate the ultimate source of light:
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... Mauritius is a seemingly idyllic and tranquil ... km (1,243 miles) off the southeastern coast of Africa, ... melting pot where everyone lives together in harmony. , ... is riddled with drug abuse. In fact, it carries ... of any nation in eastern Africa. , “Many youngsters, ...
(Date:4/20/2015)... April 20, 2015 “Consumers deserve to know ... washing their children’s hair will not put their health at ... of the National Alliance for Hispanic Health, the nation’s leading ... FDA has not had authority to ensure cosmetic and personal ... has FDA had authority to get products off the shelves ...
(Date:4/20/2015)... Advance Home Care Supply understands that ordering adult ... prefer not to share with others. As such, the company ... allowing customers to order the products and supplies they need ... a neighbor or passerby knowing what the customer has purchased. ... orders and no minimum order limit is required. Also, there ...
(Date:4/20/2015)... TROY Healthcare Solutions will be hosting ... software, which provides the ultimate level of security for ... the Anthem Suite Hotel in the Socrates Room, located ... , Beginning at 7 AM, TROY Healthcare Solutions will ... Healthcare Solutions will offer brief 15-20 minute presentations each ...
(Date:4/20/2015)... (PRWEB) April 20, 2015 Grateful Dead ... were united as one until 1995. The group was more ... blues, reggae, rock, bluegrass, folk, space rock, country, and other ... as the ultimate jam band. The group was inducted into ... in total has sold more than 35 million records worldwide. ...
Breaking Medicine News(10 mins):Health News:Voice For Humanity: Choolun Bhojoo leads the fight to rid Mauritius of a drug plague 2Health News:Statement of National Alliance for Hispanic Health on Senate Introduction of Personal Care Products Safety Act 2Health News:Advance Home Care Supply Proud to Offer Discreet Delivery For All Orders 2Health News:Advance Home Care Supply Proud to Offer Discreet Delivery For All Orders 3Health News:TROY Healthcare to Offer Prescription Solutions that Could Save a Health System $100,000 2Health News:TROY Healthcare to Offer Prescription Solutions that Could Save a Health System $100,000 3Health News:Grateful Dead Tickets at Levi’s Stadium in Santa Clara: Ticket Down Slashes Grateful Dead Tickets in Santa Clara @ Levi’s Stadium for "Fare Thee Well" 50th Anniversary 2
... , OAKLAND, Calif., Aug. 5 Anyone ... record in a standardized format understood at hospitals, clinics and ... specializing in chronic illness support, geriatric care management and private ... Your Own Health to re-brand and sell the popular ...
... , , PHOENIX, Aug. 5 ... hand must not become a vehicle for taking lives through abortion ... report at the organization,s 127th annual convention here today. Referring to ... declared that "Health care reform must be abortion-free." , , ...
... direction for diabetes treatment , WEDNESDAY, Aug. 5 (HealthDay News) ... role in the control of blood sugar production in the ... first time that CCK from the gut activates receptors to ... axis," Tony Lam of the University of Toronto said in ...
... , , , ... a privately-held specialty pharmaceutical company, today announced that it has ... IMS data indicates the combined U.S. market for these two ... and shipping both products immediately. , , ...
... an animal model that provides strong evidence why imatinib, marketed ... but does not keep the disease from returning if treatment ... drug,s radar and enable the disease to recur in most ... issue of Cancer Cell . The researchers ...
... An internationally recognized Virginia Commonwealth University physician has ... Award for his pioneering contributions that have advanced the ... past recipients who have made a remarkable impact on ... Foundation for Infectious Diseases awarded the honor to Richard ...
Cached Medicine News:Health News:Portable Health Care Records Now Available for Consumers 2Health News:'Health Care Reform Must be Abortion-Free,' says Supreme Knight 2Health News:Sagent Pharmaceuticals Announces Launch of First Two Oncolytic Products: Fludarabine Phosphate for Injection, USP and Epirubicin Hydrochloride Injection 2Health News:Finding key to cancer drug Gleevec's limitations 2Health News:National Foundation for Infectious Diseases honors VCU physician with Maxwell Finland Award for 2010 2Health News:National Foundation for Infectious Diseases honors VCU physician with Maxwell Finland Award for 2010 3
(Date:4/20/2015)... 20, 2015 International Isotopes Inc. (OTCQB: ... shareholders with the following update on its business ... Historically, INIS has produced and sold ... models of sealed sources for medical and industrial ... therapy, security examination, and radiography.  Due to technical ...
(Date:4/20/2015)... KANNAPOLIS, N.C. , April 20, 2015 /PRNewswire/ ... managed care organization that focuses on high-tech, high-touch ... for delivering behavioral health services during the National ... The event, which takes place April 20–22, 2015, ... in Orlando, Fla. , attracts ...
(Date:4/20/2015)... , April 20, 2015 Eli Lilly ... the investigational medicine ixekizumab was statistically superior to placebo ... (PsA), as demonstrated by the proportion of patients achieving ... assessment that represents a 20 percent reduction in disease ... of Rheumatology response criteria. During the 24-week, Phase 3 ...
Breaking Medicine Technology:International Isotopes Inc. Provides Shareholders With An Update On New Opportunities And Positive Developments Within Its Existing Business Segments 2International Isotopes Inc. Provides Shareholders With An Update On New Opportunities And Positive Developments Within Its Existing Business Segments 3International Isotopes Inc. Provides Shareholders With An Update On New Opportunities And Positive Developments Within Its Existing Business Segments 4International Isotopes Inc. Provides Shareholders With An Update On New Opportunities And Positive Developments Within Its Existing Business Segments 5Cardinal Innovations Highlights its Managed Care Model During National Council for Behavioral Health's Annual Conference 2Cardinal Innovations Highlights its Managed Care Model During National Council for Behavioral Health's Annual Conference 3Lilly's Ixekizumab Met Primary Endpoint in a Phase 3 Study Investigating the Treatment of Psoriatic Arthritis 2Lilly's Ixekizumab Met Primary Endpoint in a Phase 3 Study Investigating the Treatment of Psoriatic Arthritis 3Lilly's Ixekizumab Met Primary Endpoint in a Phase 3 Study Investigating the Treatment of Psoriatic Arthritis 4
... LAUSANNE, Switzerland, July 21 Debiopharm Group,(Debiopharm), ... focus on the development of prescription drugs that ... agency for therapeutic products,Swissmedic, has issued a marketing ... prescribed for a reversible reduction,of serum testosterone to ...
... Ueno, Ltd. announced on July 17 that as a phase 1 ... by our company as a therapeutic drug of androgenetic alopecia (male ... , The phase 1 clinical study of ... study and 5-day repeated-dose study. Since no serious adverse event occurred ...
Cached Medicine Technology:Swissmedic Grants Debiopharm Marketing Authorisation for Moapar(R), a New Therapeutic Avenue for the Treatment of Sexual Deviations 2Swissmedic Grants Debiopharm Marketing Authorisation for Moapar(R), a New Therapeutic Avenue for the Treatment of Sexual Deviations 3R-Tech Ueno, Ltd. Completes Phase 1 Clinical Study on RK-023 2R-Tech Ueno, Ltd. Completes Phase 1 Clinical Study on RK-023 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: